The Fondaparinux Trial With Unfractionated Heparin During Revascularization in Acute Coronary Syndromes/OASIS-8 - FUTURA/OASIS-8

Description:

The goal of the trial was to evaluate treatment with low-dose unfractionated heparin (UFH) compared with standard-dose UFH among patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) treated on a background of fondaparinux therapy.